Website profile

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

  • 17articles · 30d
  • 3+ day agolatest article
  • Aug 18, 2026earliest in window
  • 76%with images
  • 214avg words
articles per day
Categories
  • Economy, Business & Finance 15
  • Medical 11
  • Health & Wellness 11
  • Business & Industrial 5
  • Finance & Business 4
  • Health 2
  • Transportation 2
  • News 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@PharmaCommerce
pharmaceuticalcommerce.com > view > how-the-rising-risk-of-cargo-theft-is-creating-new-urgency-across-pharma-supply-chains

How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain

4+ day, 23+ hour ago   (161+ words) Pharmaceutical Commerce How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain Overhaul's Danny Ramon argues that quality and regulatory teams, not just logistics, need faster protocols and more accessible stability data, since stolen or compromised product that…...

@PharmaCommerce
pharmaceuticalcommerce.com > shorts > how-pharma-will-navigate-the-ndc-12-transition

How Pharma Will Navigate the NDC-12 Transition

1+ week, 6+ hour ago   (28+ words) Pharmaceutical Commerce Liberty Dewey, DSCSA manager at Cardinal Health, breaks down the tools Pharma will use to navigate the NDC-12 transition....

@PharmaCommerce
pharmaceuticalcommerce.com > view > beyond-the-patent-cliff-why-generics-and-biosimilars-demand-different-playbooks

Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks

1+ week, 5+ day ago   (798+ words) The biopharmaceutical landscape is in the middle of its most dramatic structural reshuffling in decades. Fueled by record numbers of loss‑of‑exclusivity (LOE) events and pressure from payers to tame specialty‑drug inflation, the industry is watching two very…...

@PharmaCommerce
pharmaceuticalcommerce.com > view > mfn-program-nine-drugmakers-manufacturing-investment

MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing

1+ week, 6+ day ago   (128+ words) Nine more manufacturers join the MFN program, pairing new Medicaid pricing deals with $19.6B in U.S. manufacturing investment and API reserve donations. The newly announced participants are a group of mid-sized manufacturers: For sourcing and procurement teams, these donations are worth tracking…...